Funding for this research was provided by:
Tiansheng Taifeng Pharm (NA)
Article History
Received: 3 November 2019
Accepted: 19 February 2020
First Online: 14 March 2020
Ethics approval and consent to participate
: Central ethical approval has been confirmed from the research ethics committee of Beijing Anding Hospital, Capital Medical University ((2017)63-201772FS-2). Local ethical approval from other participating hospitals has also been obtained. The study will be conducted in accordance with the principles of the Declaration of Helsinki. Trial organization, data management, monitoring, and reporting will also be conducted in accordance with the guidelines for Good Clinical Practice and other regulations. Patients will be given full and adequate oral and written information about the study. The consent will be provided by the patient or a legally authorized representative.
: Not applicable.
: The authors declare that they have no competing interests.